Geisthövel F, Bliefert R, Geyer H, Breckwoldt M, Sandow J
Geburtshilfe Frauenheilkd. 1987 Apr;47(4):240-5. doi: 10.1055/s-2008-1035815.
The treatment of infertile women by gonadotropins is more effective in hypogonadotropic than in normogonadotropic ovarian insufficiency. In order to induce a hypogonadotropic state the luteinizing hormone-releasing hormone analog (LHRHA) buserelin was administered in eight cycles of four infertile patients suffering from luteal phase defect. Buserelin was infused subcutaneously in a dosage of 400 micrograms/d for 26-44 days using a portable external osmotic minipump system. Following suppression of estradiol-17 beta below 35 pg/ml within 11 +/- 5 days, gonadotropins were injected intramuscularly to stimulate ovarian function. In all cycles treated, ovulation and formation of a functional corpus luteum were observed without signs of premature luteinization. Whereas constant administration of LHRHA by a slow release system seems very useful for long-term reversible suppression of follicular maturation, further studies should evaluate the clinical usefulness of combined LHRHA/gonadotropin treatment in cases of infertility.
促性腺激素治疗不育女性时,对于低促性腺激素性卵巢功能不全的疗效优于正常促性腺激素性卵巢功能不全。为诱导低促性腺激素状态,对4例患有黄体期缺陷的不育患者进行了8个周期的治疗,使用促黄体生成素释放激素类似物(LHRHA)布舍瑞林。采用便携式外部渗透微型泵系统,以400微克/天的剂量皮下输注布舍瑞林,持续26 - 44天。在11±5天内将雌二醇-17β抑制至35皮克/毫升以下后,肌肉注射促性腺激素以刺激卵巢功能。在所有治疗周期中,均观察到排卵和功能性黄体形成,且无过早黄素化迹象。虽然通过缓释系统持续给予LHRHA似乎对长期可逆性抑制卵泡成熟非常有用,但进一步的研究应评估LHRHA/促性腺激素联合治疗在不育病例中的临床实用性。